We continue our disciplined concentration on acquisition opportunities in the infection prevention and control market. Our acquisition program focuses on the expansion of existing platforms (reprocessing systems, filtration and purification, and disposable products), as well as acquisitions and other key strategic alliances which may be complimentary to, or in fact independent of, our existing business.

Recent acquisitions by Cantel include:

• GE Water & Process Technologies’ Dialysis Business (March 2007). Cantel’s Mar Cor Purification division acquired the #1 player in medical water equipment and consumables. GE’s business, formerly a part of GE Osmonics, had approximately 1,800 installations in North America with revenues of approximately $20 million. The acquisition expands Mar Cor’s water treatment division by 50%, thereby increasing the importance of water purification in Cantel’s infection prevention and control portfolio. By adding this entrenched installed base of customers, Mar Cor was able to solidify their position as the leading provider in dialysis water.
  
  
• Fluid Solutions, Inc. (May 2006). Cantel expanded its infection prevention and control business in water purification by purchasing certain assets of Fluid Solutions, inc., a privately held high purity water systems manufacturer and service company based in Lowell, Massachusetts. We have integrated Fluid Solutions into Cantel’s Water Purification and Filtration segment. This acquisition expands our customer base in the biotech, pharmaceutical, research, hospital, and semiconductor markets as well as our sales presence and resin regeneration capability in the New England area.
  
  
• Crosstex International (August 2005), based in Hauppauge, NY, enabled Cantel to establish a sizeable foothold in single-use infection control products, principally for the dental office market. With over 50 years of brand equity and a diverse, high-quality product suite, Crosstex is a true leader in its industry. Crosstex designs, manufactures, and markets more than 60% branded products that include patient towels, sterilization pouches, facemasks and shields, barrier films, ejectors and evacuators, disinfectants, soaps, lotions, and sanitizers, and cotton and gauze products.
  
  
• Saf-T-Pak Inc. (June 2004), based in Edmonton, Canada, provided Cantel with an entry into the specialized packaging and training industry for the safe handling and transportation of infectious and biological specimens. As a leader in this niche industry, Saf-T-Pak designs and manufactures a variety of unique and patented packaging that meets or exceeds all national and international regulations. Saf-T-Pak also offers compliance training services and materials, and specialized thermal control products (Saf-T-Temp™) to aid in the shipping of temperature sensitive products.
  
  
• Dyped Medical B.V. (Sept 2003), based in The Netherlands, was acquired so as to expand Minntech's technological capabilities and augment its endoscope reprocessing product line with a new, fully automated reprocessor designed to be compliant with emerging European standards and future market requirements.
  
  
• Water Treatment Entry Strategy (August 2003). Cantel embarked on the development of a new leg of our business via the simultaneous acquisitions of The Biolab Group (Toronto & Montreal, Canada) and Mar Cor Services (Skippack, PA). With exceptional engineering and manufacturing capabilities, Biolab is now our primary water treatment equipment supplier. Cantel is leveraging Biolab's advanced equipment into Mar Cor's service and distribution network throughout the eastern half of the United States. Moreover, Biolab and Mar Cor leverage existing Minntech filters and disinfectant product lines. These companies further reinforce our commitment and strength in dialysis, while simultaneously affording us with new opportunities in the pharmaceutical and biotechnology markets.
  
  
• Minntech Corporation (Sept 2001), based in Plymouth, Minnesota, further solidified our position as a leader in infection control and medical device reprocessing. Minntech is engaged in the development, manufacturing and marketing of disinfection/reprocessing systems and other products for renal dialysis and flexible endoscopy as well as filtration and separation products for medical and non-medical applications. The Minntech acquisition has more than doubled the Company's annual revenue at the time of acquisition.

Naturally, we can make no guarantees about acquisitions that have not yet been made, but our strategic plan includes a program to expand via acquisitions, as well as to grow organically at rates that surpass industry averages.

Please direct all inquiries to:

Seth Segel
Senior Vice President - Corporate Development
Cantel Medical Corp.
150 Clove Road – 9th Floor
Little Falls, NJ 07424-2139
Tel: 973-890-7220
Fax: 973-890-7270
Email: ssegel@cantelmedical.com

For information about this site, e-mail webmaster@minntech.com
© 2005 Cantel Medical Corp.   All rights reserved.
150 Clove Road - 9th Floor, Little Falls, NJ 07424-2139
Phone: (973) 890-7220, Fax: (973) 890-7270